Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 2100 to 2149 of 3228 in total
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1
\def\wcA{0.16666666666667\textwidth} \def\wcB{0.16666666666667\textwidth} \def\wcC{0.16666666666667\textwidth} \def\wcD{0.16666666666667\textwidth} \def\wcE{0.16666666666667\textwidth} \begin{longtable}{|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}\\ \hline \hline \parbox{\wcA}{\vspace{3pt}\noindent 2100\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent methionine aminopeptidase 2 (ec 3.4.11.18) (metap 2) (peptidase m 2) (initiation factor 2 associated 67 kda glycoprotein) (p67) (p67eif2). [source:swissprot;acc:p50579]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 3544.03\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 3359.43\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.05495\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2101\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent maguk p55 subfamily member 2 (mpp2 protein) (discs, large homolog 2). [source:swissprot;acc:q14168]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5241.34\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5529.25\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.05493\vspace{3pt}}}\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 2102\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent c-1-tetrahydrofolate synthase, cytoplasmic (c1-thf synthase) [includes: methylenetetrahydrofolate dehydrogenase (ec 1.5.1.5); methenyltetrahydrofolate cyclohydrolase (ec 3.5.4.9); formyltetrahydrofolate synthetase (ec 6.3.4.3)]. [source:swissprot;acc:p11586]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4860.34\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5127.3\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2103\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent asparaginyl-trna synthetase, cytoplasmic (ec 6.1.1.22) (asparagine-- trna ligase) (asnrs). [source:swissprot;acc:o43776]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6847.82\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7223.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.05486\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2104\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent protein disulfide isomerase precursor (pdi) (ec 5.3.4.1) (prolyl 4- hydroxylase beta subunit) (cellular thyroid hormone binding protein) (p55). [source:swissprot;acc:p07237]\vspace{3pt}}&\multirow{9}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 6916.14\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 7295.24\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.05481\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2105\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 3-hydroxyanthranilate 3,4-dioxygenase (ec 1.13.11.6) (3-hao) (3-hydroxyanthranilic acid dioxygenase) (3-hydroxyanthranilate oxygenase). [source:swissprot;acc:p46952]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2106\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent zinc finger protein-like 1; zinc-finger protein in men1 region. [source:refseq;acc:nm\_006782]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2107\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent hus1 checkpoint protein; hus1 (s. pombe) checkpoint homolog; hus1+-like protein. [source:refseq;acc:nm\_004507]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2108\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent hyaluronan binding protein 4; intracellular antigen detected by monoclonal antibody ki-1; intracellular hyaluronan-binding protein; chromodomain helicase dna binding protein 3 interacting protein. [source:refseq;acc:nm\_014282]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2109\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent prolyl 4-hydroxylase alpha-1 subunit precursor (ec 1.14.11.2) (4-ph alpha-1) (procollagen-proline,2-oxoglutarate-4-dioxygenase alpha-1 subunit). [source:swissprot;acc:p13674]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2110\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent homeobox prospero-like protein prox1 (prox 1). [source:swissprot;acc:q92786]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2111\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent rad1 homolog isoform 1; exonuclease homolog rad1; cell cycle checkpoint protein rad1 a/b; rad1-like protein; cell cycle checkpoint protein hrad1; dna repair exonuclease (rec1); dna repair protein rad1; rad1-like dna damage checkpoint protein. [source:refseq;acc:nm\_002853]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2112\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent prolyl 4-hydroxylase alpha-2 subunit precursor (ec 1.14.11.2) (4-ph alpha-2) (procollagen-proline,2-oxoglutarate-4-dioxygenase alpha-2 subunit). [source:swissprot;acc:o15460]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2113\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent rna-binding protein 9 (rna binding motif protein 9) (hexaribonucleotide binding protein 2) (repressor of tamoxifen transcriptional activity). [source:swissprot;acc:o43251]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5776.79\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6092.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.0547\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2114\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 60s ribosomal protein l3-like. [source:swissprot;acc:q92901]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 3617.81\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 3430.31\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.05466\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2115\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 60s ribosomal protein l23 (l17). [source:swissprot;acc:p23131]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 3672.49\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 3482.34\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.0546\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2116\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent brca2 and cdkn1a-interacting protein isoform bccipalpha; brca2 and cdkn1a-interacting protein; cdk inhibitor p21 binding protein; bccipalpha; bccipbeta; tok-1alpha; tok-1beta. [source:refseq;acc:nm\_016567]\vspace{3pt}}&&&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 2117\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ataxin 2-binding protein. [source:swissprot;acc:q9nwb1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5778.16\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6093.65\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2118\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent guanylate kinase (ec 2.7.4.8) (gmp kinase). [source:swissprot;acc:q16774]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5620.55\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5926.71\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.05447\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2119\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent lamin a/c (70 kda lamin). [source:swissprot;acc:p02545]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5976.96\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6301.73\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.05434\vspace{3pt}}}\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 2120\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent c316g12.2 (novel protein similar to predicted yeast, worm and archae- bacterial proteins) (similar to und313) (s. cervisiae) (hypothetical protein). [source:sptrembl;acc:q9ujk0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6951.29\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7329\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2121\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent centaurin beta 5 (cnt-b5). [source:swissprot;acc:q96p50]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 5977.03\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6301.76\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.05433\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2122\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent centaurin beta 2 (cnt-b2). [source:swissprot;acc:q15057]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2123\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent centaurin beta 1 (cnt-b1). [source:swissprot;acc:q15027]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2124\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent lamin b1. [source:swissprot;acc:p20700]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5977.09\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6301.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.05432\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2125\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ribosomal protein s27-like protein; 40s ribosomal protein s27 isoform. [source:refseq;acc:nm\_015920]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4806.38\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5067\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.05422\vspace{3pt}}}\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 2126\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 40s ribosomal protein s27 (metallopan-stimulin 1) (mps-1). [source:swissprot;acc:p42677]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4806.33\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5066.92\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2127\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent eukaryotic translation initiation factor 3 subunit 11 (eif-3 p25) (eif3k) (muscle specific gene m9 protein) (ptd001) (hspc029) (arg134). [source:swissprot;acc:q9ubq5]\vspace{3pt}}&\multirow{8}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 5328.73\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 5616.59\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.05402\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2128\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent erythroid differentiation and denucleation factor 1. [source:swissprot;acc:o60584]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2129\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent bardet-biedl syndrome 7 protein isoform a; bbs2-like 1. [source:refseq;acc:nm\_176824]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2130\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ba508n22.1 (hspc025) (fragment). [source:sptrembl;acc:q9hcw5]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2131\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent lipopolysaccharide-responsive and beige-like anchor protein (cdc4-like protein) (beige-like protein). [source:swissprot;acc:p50851]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2132\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent protein c20orf45 (cgi-107). [source:swissprot;acc:q9y3b1]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2133\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent eukaryotic translation initiation factor 3 subunit 6 interacting protein (hspc021/hspc025). [source:swissprot;acc:q9y262]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2134\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent putative rna-binding protein 7 (rna binding motif protein 7). [source:swissprot;acc:q9y580]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2135\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent exocyst complex component sec6. [source:swissprot;acc:o60645]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 7387.42\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7785.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.05388\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2136\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 60s ribosomal protein l19. [source:swissprot;acc:p14118]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 3687.49\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 3499.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.05381\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2137\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent sh3 domain-binding glutamic acid-rich protein (sh3bgr protein) (21- glutamic acid-rich protein) (21-garp). [source:swissprot;acc:p55822]\vspace{3pt}}&\multirow{11}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 5859.1\vspace{3pt}}}&\multirow{11}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6173.7\vspace{3pt}}}&\multirow{11}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.05369\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2138\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent oxidation resistance 1. [source:refseq;acc:nm\_181354]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2139\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent lats, large tumor suppressor, homolog 2; lats (large tumor suppressor, drosophila) homolog 2. [source:refseq;acc:nm\_014572]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2140\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dymeclin. [source:refseq;acc:nm\_017653]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2141\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent sh3 domain-binding glutamic acid-rich-like protein. [source:swissprot;acc:o75368]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2142\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent lats homolog 1. [source:refseq;acc:nm\_004690]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2143\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent sh3 domain-binding glutamic acid-rich-like protein 2 (fovea-associated sh3 domain binding protein). [source:swissprot;acc:q9ujc5]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2144\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent nuclear receptor coactivator 7; estrogen receptor associated protein 140 kda. [source:refseq;acc:nm\_181782]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2145\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dj132f21.2 (contains a novel protein similar to the l82e from drosophila) (fragment). [source:sptrembl;acc:q9h125]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2146\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent tbc1 domain family protein c22orf4-like (fragment). [source:swissprot;acc:q9nu19]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2147\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent tbc1 domain family protein c22orf4. [source:swissprot;acc:q8wua7]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2148\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent deoxycytidylate deaminase (ec 3.5.4.12) (dcmp deaminase). [source:swissprot;acc:p32321]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4644.58\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4892.06\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.05328\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2149\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent importin beta-2 subunit (karyopherin beta-2 subunit) (transportin) (m9 region interaction protein) (mip). [source:swissprot;acc:q92973]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5778.62\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6086.03\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.0532\vspace{3pt}}\\\hline nd{longtable}
Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
- Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
- Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
- Filtered specifies whether we only included the high confidence microarry measurements or not.

- http://analysis.yellowcouch.org/